March 6 (Reuters) -

* BOUNDLESS BIO INC FILES FOR IPO - SEC FILING

* BOUNDLESS BIO INC SAYS APPLIED TO LIST COMMON STOCK ON

NASDAQ

UNDER SYMBOL "BOLD"

* BOUNDLESS BIO INC SAYS GOLDMAN SACHS & CO LLC, LEERINK

PARTNERS,

PIPER SANDLER AND GUGGENHEIM SECURITIES ARE UNDERWRITERS TO IPO

* BOUNDLESS BIO INC SAYS BAYER HEALTHCARE LLC BENEFICIALLY

OWNED

9.2% OF SHARES PRIOR TO OFFERING

* BOUNDLESS BIO INC SAYS ENTITIES AFFILIATED WITH FIDELITY

BENEFICIALLY OWNED 14.8% OF SHARES PRIOR TO OFFERING

* BOUNDLESS BIO INC SAYS ENTITIES AFFILIATED WITH ARCH

VENTURE

PARTNERS BENEFICIALLY OWNED 15.6% OF SHARES PRIOR TO OFFERING

* BOUNDLESS BIO INC SAYS ENTITIES AFFILIATED WITH RA CAPITAL

MANAGEMENT BENEFICIALLY OWNED 11.7% OF SHARES PRIOR TO OFFERING

* BOUNDLESS BIO INC SAYS ENTITIES AFFILIATED WITH NEXTECH VI

ONCOLOGY SCSP BENEFICIALLY OWNED 7.4% OF SHARES PRIOR TO

OFFERING

* BOUNDLESS BIO INC SAYS NEVER DECLARED OR PAID ANY CASH

DIVIDENDS

ON CAPITAL STOCK; CURRENTLY INTENDS TO RETAIN FUTURE EARNINGS

Source text for Eikon:

Further company coverage: [ ]